Diabetes
Conditions
Brief summary
This proposal aims to demonstrate the feasibility and acceptability of adapting TEAMcare for patients with schizophrenia. The aim of this innovative mental health center-based team intervention is to improve diabetes, cardiovascular and psychiatric outcomes among patients with poorly controlled type 2 diabetes. The study will be conducted in two phases over the 2-year grant period. Phase 1. Development of the adapted TEAMcare intervention and training of team members. Phase 2. During year 2, we will implement the intervention on the caseload of 40 outpatients at Harborview Mental Health Services with schizophrenia and poorly controlled type 2 diabetes. The intervention involves the management of subjects' diabetes, hypertension, and hyperlipidemia by a CMHC diabetes team for 6 months (advanced nurse specialist on-site at supervised in weekly meetings by a psychiatrist and a UW Diabetes Center endocrinologist). The primary aim of this pilot research grant is to evaluate the feasibility of implementing this complex intervention, in order to guide the design of a larger scale efficacy study (R01). Both process and outcome measures will be evaluated at baseline, and at 3- and 6-month follow-up visits for the 40 subjects enrolled in this feasibility trial.
Interventions
OTHERTEAMcare treatment of diabetes
TEAMcare is an evidence-based collaborative care approach to the treatment of diabetes and psychiatric illness. It involves structured visits with a study nurse to monitor psychiatric symptoms, control of medical disease, and self-care activities. The nurses use motivational coaching to help patients solve problems and set goals for improved self-care and medication adherence. Medications for diabetes, hypertension, and hyperlipidemia are monitored and therapy intensified based on treat-to-target guidelines. All of these process and outcome measures are tracked in a registry designed for the study, and the nurses receive weekly supervision with a psychiatrist, an endocrinologist and a psychologist in order to review new cases and to track progress. Once a patient achieves targeted levels for relevant measures, the patient and the nurse develop a maintenance plan.
Sponsors
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Washington
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* adult (18-70 years); * enrolled to receive mental health treatment at Harborview Mental Health Services or Downtown Emergency Services Mental Health center * a diagnosis of type 2 diabetes mellitus or cardiovascular disease * Hemoglobin A1c \>8 or BP \> 140/90
Exclusion criteria
* cognitive, hearing, or language impairment that would preclude a subject from providing informed consent; * current suicidality, homicidality, or grave disability that requires psychiatric hospitalization; * current substance abuse or dependence, as defined by SCID.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin A1c | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Blood Pressure | 6 months |
| LDL cholesterol | 6 months |
Other
| Measure | Time frame |
|---|---|
| Brief Psychiatric Rating Scale (BPRS) | 6 months |
Countries
United States
Outcome results
None listed